KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-alpha production. KAG-308 shows a Ki and an EC50 of 2.57 nM and 17 nM for human EP4 receptor, respectively, more selective over EP1, EP2, EP3 and IP receptor[1].
Molecular Weight:
460.52
Purity:
99.64
CAS Number:
[1215192-68-9]
Formula:
C24H30F2N4O3
Target:
Prostaglandin Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
